Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05039723 · ClinicalTrials.gov registry record · Phase 4
Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational
A Phase 4 study of Photoaging, sponsored by Main Line Center for Laser Surgery.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT05039723 is a Phase 4 study of Photoaging that has completed, run by Main Line Center for Laser Surgery. The registered enrollment target is 22 participants, below the 30-participant average among 14 other Photoaging trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05039723, a Phase 4 study of Photoaging, has completed, sponsored by Main Line Center for Laser Surgery.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the improvement in signs of photoaging and subject satisfaction after combination, global facial and/or neck treatment with IncobotulinumA (Xeomin), HA (Belotero) and/or calcium hydroxyapatite (Radiesse+, Radiesse Classic). All products will be used on-label FDA-cleared indications.
Conditions Studied
Interventions
- DRUG Radiesse, Xeomin, Belotero
Study Locations (1)
Pennsylvania
- Main Line Center for Laser Surgery - Ardmore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05039723
The ClinicalTrials.gov registry entry for NCT05039723 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 30-participant average among 14 other Photoaging trials with a reported enrollment target (27% lower). The listed sponsor is Main Line Center for Laser Surgery, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Photoaging appearing as the primary indexed condition, and to 1 intervention - of which Radiesse, Xeomin, Belotero is the first listed.
NCT05039723 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05039723 about?
NCT05039723 is a clinical study titled "Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational". The purpose of this study is to determine the improvement in signs of photoaging and subject satisfaction after combination, global facial and/or neck treatment with IncobotulinumA (Xeomin), HA (Belotero) and/or calcium hydroxyapatite (Radiesse+, Radiesse Classic). All products will be used on-label...
What is the current status of trial NCT05039723?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2021-09-01. Estimated completion is 2022-07-01.
What conditions does trial NCT05039723 study?
This clinical trial studies the following conditions: Photoaging.
What interventions are being tested in trial NCT05039723?
The interventions under investigation include: Radiesse, Xeomin, Belotero (DRUG).
Who is sponsoring clinical trial NCT05039723?
This trial is sponsored by Main Line Center for Laser Surgery, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05039723 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photoaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles
COMPLETED · Phase 4
-
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Effect of Platelet Rich Plasma on Photoaged Skin
ACTIVE NOT RECRUITING · Phase 1
-
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
COMPLETED · NA
-
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.